क्यूआर कोड

Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens

Abstract Background Etravirine (ETR), a non-nucleoside reverse transcriptase inhibitor (NNRTI) available in France since 2006, is indicated for antiretroviral-experienced HIV-infected adults, in combination with a ritonavir-boosted protease inhibitor (PI). To assess its clinical impact in routine ca...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Valérie Potard, Cécile Goujard, Marc Antoine Valantin, Jean Marc Lacombe, Rima Lahoulou, Arnaud Chéret, Pierre Marie Girard, Dominique Costagliola, French Hospital Database on HIV (FHDH - ANRS CO4)
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMC 2018-07-01
श्रृंखला:BMC Infectious Diseases
विषय:
Antiretroviral experienced HIV-infected individuals
Etravirine
Hospitalization rates
ऑनलाइन पहुंच:http://link.springer.com/article/10.1186/s12879-018-3231-5
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन